From Targeted Therapy to Immune Checkpoint Inhibition

(UroToday.com) The 2020 American Society of Clinical Oncology (ASCO) virtual education program featured a session on the evolution of renal cell carcinoma (RCC) treatment, including a presentation by renowned oncologist Dr. Bernard Escudier discussing the evolution from targeted therapy to immune checkpoint inhibition. The rationale for antiangiogenic therapy in RCC is that RCC is a tremendously vascular […]

Predictors of survival, healthcare resource utilization, and healthcare costs in veterans with non-metastatic castration-resistant prostate cancer.

The objective of this study was to evaluate the association of prostate-specific antigen doubling time (PSADT) with metastasis-free survival (MFS) and overall survival (OS), and to describe healthcare resource utilization (HRU) and costs among patients with non-metastatic castrate-resistant prostate cancer (nmCRPC) in the Veterans Health Administration setting.

Non-invasive and surgical interventions of penile enhancement for aesthetic or therapeutic purposes: a systematic review.

Despite the lack of guidelines, a wide variety of non-invasive and surgical interventions for penile enhancement with aesthetic and therapeutic purposes is available. To systematically review the literature in order to investigate the efficacy and safety of surgical and non-invasive penile enhancement procedures for aesthetic and therapeutic purposes.

Surgical Management of Urolithiasis of the Upper Tract – Current Trend of Endourology in Africa.

Urolithiasis is a global pathology with increasing prevalence rate. The lifetime recurrence of urolithiasis ranges from 10-75% creating a public health crisis in affected regions. The epidemiology of urolithiasis in most parts of Africa and Asia remains poorly documented as incidence and prevalence rates in these settings are extrapolated from hospital admissions.

X